Financial Year |
March 31 2023 |
Monetary Funds |
152,617,506.95 |
Held-for-trading Financial Assets |
97,330,141.61 |
Notes Receivable |
33,341,910.54 |
Accounts Receivable |
234,177,537.62 |
Advances to Suppliers |
9,656,854.81 |
Other Receivables |
90,071,465.31 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
141,235,597.39 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
18,552,690.10 |
Total Current Assets |
805,604,128.57 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
81,367,432.37 |
Under-construction Projects |
97,011,671.03 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
14,771,499.15 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
33,446,377.25 |
Other Non-Current Assets |
2,018,982.46 |
Sub-Total of Non-Current Assets |
229,534,705.84 |
Total Assets |
1,035,138,834.41 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
38,900,000.00 |
Accounts Payable |
143,419,066.99 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
2,664,806.58 |
Taxes Payable |
819,660.49 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,774,957.49 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
176,598.93 |
Other Current Liabilities |
9,389,411.92 |
Sub-Total of Current Liabilities |
337,634,452.12 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
1,994,710.18 |
Deferred Income Tax Liabilities |
3,239,312.84 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
6,129,683.16 |
Total Liabilities |
343,764,135.28 |
Paid-In Capital(Or Share Stock) |
240,146,000.00 |
Capital Surplus |
253,405,494.27 |
Surplus Reserve |
32,941,298.27 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
155,946,879.21 |
Minority Stockholder's Interest |
291,427.92 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
691,083,271.21 |
Owner's Equity(Stockholder's Equity) |
691,374,699.13 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,035,138,834.41 |